about
Stability of a trivalent recombinant protein vaccine formulation against botulinum neurotoxin during storage in aqueous solutionPost-intoxication inhibition of botulinum neurotoxin serotype A within neurons by small-molecule, non-peptidic inhibitors.A pilot prospective study to evaluate whether the bladder morphology in cystography and/or urodynamic may help predict the response to botulinum toxin a injection in neurogenic bladder refractory to anticholinergics.Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors.Analysis of Botulinum Neurotoxin Serotype A Metalloprotease Inhibitors: Analogs of a Chemotype for Therapeutic Development in the Context of a Three-Zone PharmacophoreBotulinum toxin A in the overactive bladder: current status and future directions.Survival of a Foal with Type A Botulism.Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.Synaptic vesicle chips to assay botulinum neurotoxins.Escherichia coli verotoxin 1 mediates apoptosis in human HCT116 colon cancer cells by inducing overexpression of the GADD family of genes and S phase arrest.Neurologic uses of botulinum neurotoxin type A.The first non Clostridial botulinum-like toxin cleaves VAMP within the juxtamembrane domain.Repetitive stimulation of the common peroneal nerve as a diagnostic aid for botulism in foals.Effect of botulinum neurotoxin treatment in the lateral spread monitoring of microvascular decompression for hemifacial spasm.Specificity of botulinum protease for human VAMP family proteins.
P2860
Q30371202-EB5BA332-365E-41E6-9EBE-B5174DC3FF3CQ34070655-E53A9848-D090-4D3D-A42D-64418B2EA16AQ34071968-1C06D012-4D54-431F-84AD-0909FA4D50A6Q34074218-679E0AAB-89E3-4611-96B2-0CC5CFC3B5FDQ34317228-EA248DF8-4553-4039-BC97-3B1F5763F468Q36741471-DC380A8B-A3FC-461F-B756-2CB8720DFFA6Q37020286-A50394B7-2F4B-4753-8242-ED0E3C3D04F3Q39207459-A64E8197-091B-48EA-B891-B348FE79DA17Q39499527-A0A324FB-4A34-4236-B2CD-445CB2489203Q40349623-698F86A6-EBBB-48EC-AEE3-AEF7C6EB6A97Q42086848-29F4BD2D-BF9B-4E6F-A19A-2466F8CB327AQ42408273-89E53487-1D7B-44E7-9D05-34E15E8D07DAQ46222725-3832A0E3-FE32-4BAB-8F9D-8FA5619C9334Q51016593-6ADF9EED-2B88-48C0-9B6B-A55F12A49F6FQ55055611-8B41179E-AC1D-4826-9FFF-148A1CB957DE
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Botulinum toxins in neurological disease.
@ast
Botulinum toxins in neurological disease.
@en
type
label
Botulinum toxins in neurological disease.
@ast
Botulinum toxins in neurological disease.
@en
prefLabel
Botulinum toxins in neurological disease.
@ast
Botulinum toxins in neurological disease.
@en
P2860
P356
P1433
P1476
Botulinum toxins in neurological disease.
@en
P2093
Cynthia L Comella
Seth L Pullman
P2860
P304
P356
10.1002/MUS.20033
P577
2004-05-01T00:00:00Z